Journal of Medicinal Chemistry · 1996 · 225 citations · 25 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryDrug DesignProdrug DesignAnticancer Prodrug DesignDrug Delivery EngineeringDrug DispositionPharmacokinetics Of Anticancer DrugsPharmacokinetics Of Polymer CarriersPolymer-conjugated ProdrugsPolymeric ProdrugsProdrug Toxicity Evaluation
Water soluble 2'-taxol poly(ethylene glycol) (PEG) esters have been synthesized and shown to function in vitro as prodrugs. However, in vivo experiments clearly establish that in order for these prodrugs to behave in a predictable fashion, the molecular weight of PEG must be of such magnitude so as to maintain a t1/2(circulation) > t1/2(hydrolysis). When PEG derivatives of molecular weight approximately 40 kDa were employed with paclitaxel, ca. 4% by weight of paclitaxel was carried by the water soluble prodrug form, and equivalent in vivo toxicity and increased life expectancy in the P388-treated mouse was observed. An effective method for prescreening prodrugs was found to be the acute murine lethality, which reflects the equivalency of the solubilized transport form and the native drug.
25
Leonard W. Seymour, Ruth Duncan, J. Strohalm et al. · Journal of Biomedical Materials Research · 1987 · 429 citations
Attachment of drugs to polyethylene glycols
Samuel Zalipsky, Chaim Gilon, Albert Zilkha · European Polymer Journal · 1983 · 347 citations